ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176507 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176507; 2) Community: the network communities that were significantly associated with the response to NSC 176507; 3) Molecule: the relationships between components within communities and NSC 176507; 4) MDR: the compounds that were significantly associated with the NSC 176507.

NSC Compound Enrichment Correlation
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0220039422291538 0.37133049
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0220039422291538 0.23771668
NSC 79304 Null 0.0220039422291538 0.54299122
NSC 9706 Triethylenemelamine 0.0220039422291538 0.13048128
NSC 99027 Null 0.0220039422291538 0.48865622
NSC 53861 Null 0.0220039422291541 0.11864891
NSC 641225 Null 0.0220039422291541 0.19817959
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0220039422291541 0.25691832
NSC 100071 component of Halotex 0.0228801759885687 0.57128423
NSC 102810 D-ARABINOSE, 5-O-TRITYL-TRIBENZOATE 0.0228801759885687 0.51245139
Total:87  Current:45    [First] [Prev] [Next] [Last]